Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors ’ Rehabilitation Evaluation after CANcer (SURECAN) trial

DiscussionTo date, there have been no robust trials reporting both clinical and cost-effectiveness of an ACT based intervention for people with low QoL after curative cancer treatment in the UK. We will provide high quality evidence of the effectiveness and cost-effectiveness of adding ACT+ to usual aftercare provided by the NHS. If shown to be effective and cost-effective then commissioners, providers and cancer charities will know how to improve QoL in cancer survivors and their families.Trial registrationISRCTN:ISRCTN67900293. Registered on 09 December 2019.All items from the World Health Organization Trial Registration Data Set for this protocol can be found in Additional file 2 Table S1.
Source: Trials - Category: Research Source Type: clinical trials